BARCELONA, Spain, Sept. 6 /PRNewswire/ -- Elekta, a world leader in radiation oncology and non-invasive neurosurgery solutions, will showcase the latest advances in radiotherapy, stereotactic radiosurgery and clinical workflow solutions at the European Society of Therapeutic Radiation Oncologists (ESTRO) 2007 meeting in Barcelona, Spain, September 8-13. More than 2,000 physicists, radiotherapists, oncologists and other health care professionals are expected at the Ninth Biennial ESTRO meeting on Physics and Radiation Technology for Clinical Radiotherapy at the Palau de Congresos de Catalunya. Monday, September 10 at 11 a.m. CEST, Tomas Puusepp, President and CEO of Elekta, will unveil an innovative new radiation therapy system in the Elekta booth (No. 4-6) that will help expand the ability to provide precision radiation therapy and bring advanced cancer treatment to many more patients around the world.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )
“This new product is yet another advancement as we continually expand and enhance our portfolio of cancer treatment solutions to offer more effective and efficient options to a broader range of health care providers, regardless of size,” says Puusepp. “We are pleased to present this along with our other innovations that help optimize treatment efficacy and workflow.”
Broad range of solutions on display
Elekta’s theme at ESTRO this year is “Moving forward together.” For the first time at ESTRO, Elekta will showcase the entire Elekta family of products, services, and companies, including Elekta’s flagship products together with integrated product innovations from past Elekta company acquisitions. Elekta will have on display product solutions for providing precise radiation therapy, image guidance, stereotactic neuroscience, functional mapping and information systems management.
Elekta will also have on display its premier image guided stereotactic treatment management system, Elekta Axesse(TM), which combines integrated 3D X-ray Volume Imaging with high-resolution radiation delivery and robotic 6D patient positioning, and the new Leksell Gamma Knife(R) Perfexion(TM), the revolutionary advancement in stereotactic radiosurgery that extends treatment reach and offers workflow benefits. Workflow technology such as MOSAIQ(TM) and SYNERGISTIQ(TM) developed by IMPAC Medical Systems, an Elekta company, will also be featured in the booth, along with an array of patient positioning and immobilization systems such as HeadFIX(R), BodyFIX(R), and HexaPOD(TM).
An announcement on new offerings by Elekta in Volumetric Intensity Modulated Arc Therapy (VMAT)* technique, which moves both collimator leaves and gantry during radiotherapy, will compare Elekta’s VMAT solutions to other forms of radiation therapy. Performing VMAT together with Elekta’s proven X- ray Volume Imaging can help clinicians reduce treatment time, and the technique also enables helical-like conformality. Olof Sanden, Executive Vice President Region Europe at Elekta says, “Elekta is moving forward together by fully integrating and incorporating our total portfolio within one sales offering. We are moving forward in a clinical and technical direction with 4D IGRT, IGTM, VMAT, Image Guided Stereotactic Solutions, and in a customer- oriented direction by optimizing clinical workflow solutions based on listening to user needs.”
Symposium to feature customer experiences
On September 10, Elekta is hosting a lunch symposium, “Moving forward together: the customers’ experience of Elekta solutions.” The symposium will feature presentations on the latest cancer care solutions in Image Guided Treatment Management, such as IGRT, VMAT, patient positioning and management information systems, presented by users from Malaga, Amsterdam and Mannheim. An open discussion will take place after the symposium.
Elekta also will hold a European Users’ meeting September 7 at the Hotel Rey Juan Carlos I in Barcelona. Elekta Users will attend presentations on Elekta Treatment Solutions for management information systems, IGRT and VMAT.
*VMAT is a work in progress and currently not available for distribution.
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include, among others, Leksell Gamma Knife(R) product line for non-invasive treatment of brain disorders, Elekta Axesse(TM) for Image guided Stereotactic treatments, and Elekta Synergy(R) for intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world’s largest supplier of oncology software.
Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approximately 2,000 employees, Elekta’s corporate headquarters is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGOPRN Photo Desk, photodesk@prnewswire.comElekta, Inc.
CONTACT: Product inquiries, Peter J. Gaccione, Vice President, GlobalMarketing, Elekta, +1-770-670-2380 USA, + 44 (0) 1293 65 8446 England,peter.gaccione@elekta.com; or Investor inquiries, Peter Ejemyr, Group VPCorporate Communications, Elekta AB, mobile, +46 733 611 000,peter.ejemyr@elekta.com
Web site: http://www.elekta.com//
